Semaglutide impairs bioavailability of alectinib: a note of warning based on a cross‐over pharmacokinetic drug‐drug interaction study
Elisabeth F. C. van Rossum, Marthe S. Paats, Anne‐Marie C. Dingemans, N. Heersche et al.
Local Database Links
1 links
Journal
Cancer Communications
Topics
Colorectal Cancer Treatments and Studies
article
Semaglutide impairs bioavailability of alectinib: a note of warning based on a cross‐over pharmacokinetic drug‐drug interaction study
Elisabeth F. C. van Rossum, Marthe S. Paats, Anne‐Marie C. Dingemans, N. Heersche, Ron HN van Schaik, Abdullah İçli, Esther Oomen‐de Hoop, Peter de Bruijn, Stijn L.W. Koolen, Ron H.J. Mathijssen, D. Lanser, G. Veerman
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Semaglutide impairs bioavailability of alectinib: a note of warning based on a cross‐over pharmacokinetic drug‐drug interaction study — Elisabeth F. C. van Rossum, Marthe S. Paats, et al. · Cancer Communications (2025) | TGRS Research Map | TGRS